Japan to India: Extract Import Trade Route

The Japan to India Extract corridor is one of India's established pharmaceutical import routes from Japan, with 1 shipments documented worth a combined $0 USD. The route is dominated by SSP CO LIMITED, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Japan's extract export sector.

Across 1 active Japan suppliers, the average shipment value stands at $0 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with extract's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 28.8%, placing it at rank #8 among India's top extract import origins globally.

On the Indian buyer side, key Indian importers include SANOFI HEALTHCARE INDIA PRIVATE LIMITED. SANOFI HEALTHCARE INDIA PRIVATE LIMITED is the single largest Indian importer with 1 shipments valued at $0 USD.

India's extract imports from Japan are driven primarily by a handful of large-scale Japan manufacturers. SSP CO LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Japan supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SSP CO LIMITED — together account for 100% of total trade value on this route. The average shipment value of $0 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, SANOFI HEALTHCARE INDIA PRIVATE LIMITED is the largest importer with 1 shipments worth $0 USD — representing 100% of all extract imports from Japan on this route.